Juvenile Gaucher Disease (Type III/Subacute Neuronopathic)


Risk

  • Less than 1:100,000

  • Autosomal recessive with no sex predominance

  • Panethnic but more common in Northern Sweden and Palestinian town of Jenin

Perioperative Risks

  • Abnormal platelet functioning and increased risk of bleeding

  • Respiratory failure

  • Seizure

Worry About

  • Intraoperative blood loss and need for transfusion of PRBC, FFP, and platelets

  • Perioperative continuation of anticonvulsant therapy and possible need to supplement

  • GERD and aspiration

  • Potential presence of restrictive or obstructive lung pathology

  • Potential presence of pathologic fractures, including vertebrae

  • Type IIIc disease: Intracardiac calcifications—mitral valve, aortic valve, ascending aorta, aortic arch, and coronary ostia

Overview

  • Variable clinical expression and severity; presents along a continuum.

  • Systemic involvement often present in all forms of Gaucher disease, including type III:

    • Splenomegaly, which may lead to anemia, thrombocytopenia, and leukopenia.

    • Platelet dysfunction independent of splenic involvement.

    • Decrease in coagulation factors.

    • Hepatomegaly.

    • Skeletal involvement, including bone marrow infiltration, osteonecrosis/osteoporosis, and pathologic fractures.

  • Systemic involvement more common in type III disease:

    • Pulm involvement, including interstitial lung disease, pulm Htn, or hepatopulmonary syndrome.

    • GERD with chronic aspiration.

  • Specific to type III disease:

    • Slowly progressive neurologic symptoms.

    • Supranuclear horizontal gaze palsy is pathognomonic sign.

    • Seizures may be present.

    • Oculomotor apraxia.

    • Three subtypes:

      • Type IIIa: Myoclonus; dementia

      • Type IIIb: Early onset of isolated horizontal supranuclear gaze palsy; aggressive systemic illness

      • Type IIIc: Intracardiac calcifications—mitral valve, aortic valve, ascending aorta, aortic arch, and coronary ostia

Etiology

  • Autosomal recessive deficiency of the lysosomal enzyme acid beta-glucosidase.

  • Results in accumulation of glucosylceramide in various tissues, most often lysosomes of macrophages.

    • Can lead to macrophage clumping in liver, spleen, and bone marrow.

    • Hypersplenism may result in anemia, thrombocytopenia, and leukopenia.

    • May also accumulate in lungs, skin, conjunctiva, kidneys, and heart.

  • Specific to type III (juvenile Gaucher):

    • Most common mutation is a variant of L444P, but other missense/null mutations may occur.

    • Type IIIa: No specific mutation.

    • Type IIIb: Predominantly homozygous mutation of L444P.

    • Type IIIc: Homozygous mutation of D409H.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here